reduce the fasting blood-glucose, serum urea, creatinine, TC and TG; reduce glomerular sclerosis and renal fibrosis; reduce proinflammatory burden through the axis of MAPK/NF-κB/STAT3/cytokine. This evidence concerns the gene NFKB1 and glomerulosclerosis.